Biophytis Announces Its Participation in Two Major Investor Conferences in January, In the United States and In France: The JP Morgan Healthcare Conference and The Invest Securities Biomed

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / January 5, 2023 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), (“Biophytis” or the “company”) a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19…
Read More

About The Author

Jonathan Jeriah

See author's posts